MLchartDataset catalogue

menatetrenone

Term · Oncology and biomedicine · MLC-T-ONC-015089

A menaquinone compound and form of vitamin K2 with potential antineoplastic activity. Menatetrenone may act by modulating the signalling of certain tyrosine kinases, thereby affecting several transcription factors including c-myc and c-fos. This agent inhibits tumor cell growth by inducing apoptosis and cell cycle arrest.

Table 1. Record
IdentifierMLC-T-ONC-015089
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015089",
  "term": "menatetrenone",
  "field": "Oncology and biomedicine",
  "definition": "A menaquinone compound and form of vitamin K2 with potential antineoplastic activity. Menatetrenone may act by modulating the signalling of certain tyrosine kinases, thereby affecting several transcription factors including c-myc and c-fos. This agent inhibits tumor cell growth by inducing apoptosis and cell cycle arrest.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/menatetrenone/"
}

Record 10,830 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.